The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

Innovations in Rapid HIV Testing Fuel Market Expansion as Vendors Compete for Market Share HIV Rapid Test Kits Market HIV Rapid Test Kits Market Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "HIV ...

The U.S. government reopened the program in September, allowing any household to order up to four at-home COVID nasal swab ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of antiretrovirals to one-month refills since the U.S. government froze foreign ...

Uganda had deployed special forces in South Sudan’s capital, Juba, to ‘secure it’, said Uganda’s military chief on Tuesday, ...

Philadelphia announced in 2020 that the city would be participating in an initiative to “end” the HIV epidemic by reducing ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The global HIV diagnostics market, valued at US$2.96B in 2024, is forecasted to grow at a 10.3% CAGR, reaching US$3.25B by ...

Home-based HIV counseling and relationship building improved HIV testing, diagnoses and viral suppression among pregnant ...

STORY: At a children’s home in Kenya's capital Nairobi, children living with HIV/AIDS play. But the staff here fear for their ...